News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

Treated prostate cancer cells (Mateus Crespo/Prof Johann de Bono, the ICR)
Genetic testing can help deliver precision medicine to men with advanced prostate cancer

06/07/16

Genetic testing in men with advanced prostate cancer could pick up a significant proportion whose disease may be caused by inherited mutations in genes involved in repairing DNA damage, a major new study reveals.
Myeloma of sphenoid sinus. Wellcome Images / Creative Commons by-nc-nd 4.0
New genetic findings help explain inherited predisposition to myeloma

01/07/16

Researchers have identified eight new genetic variations in the human genome that could be linked to an increased risk of developing myeloma.
ICR Logo
Leukaemia drug shows potential for rarer type of ovarian cancer

30/06/16

A drug already approved for leukaemia patients could also be used to treat a specific type of ovarian cancer, according to new research.
ICR Logo
Using ultrasound to navigate the path of cancer treatment

28/06/16

Sound waves that the human ear can’t detect help animals create a picture of unfamiliar environments. Now, researchers believe sound waves could be a surprising way of helping us select the best cancer therapy for an individual.
Bioassay (Jan Chlebik for the ICR 2011)
Landmark study gives clearest picture of genetic causes of bowel cancer

22/06/16

A landmark study has given the most detailed picture yet of the genetics of bowel cancer — the UK's fourth most common cancer.
ICR Logo
New radiotherapy regime for prostate cancer could save NHS tens of millions per year

20/06/16

A shorter course of prostate cancer radiotherapy, involving fewer hospital visits and higher individual doses of radiotherapy, is as effective as the current standard treatment for both survival and quality of life, a major new study reports.
ICR Logo
UK first: microscope uses tractor beams to peer inside cells

16/06/16

The Institute of Cancer Research, London, will be the first research organisation in the UK to receive a new type of high-tech microscope, allowing scientists to view dynamic cellular processes in real time. Liz Burtally finds out how this powerful machine will help researchers to design a new generation of drugs that target cell division.
ICR Logo
Whole-body scans could track cancer in patients’ skeletons

15/06/16

Magnetic resonance imaging (MRI) could monitor aggressive cancer that has spread to the bone anywhere in the body, a new study reveals.
Radiotherapy IMRT Jan Chlebik/the ICR
Targeted radiotherapy for head and neck cancer could reduce the risk of dry mouth

14/06/16

Changing the intensity of radiotherapy to protect the salivary glands could help treat a rare type of head and neck cancer and improve patients’ day-to-day lives, a new study shows.
ICR Logo
CBE for eminent ICR researcher in Queen’s Birthday Honours

10/06/16

Professor Nazneen Rahman, a world-leading scientist from The Institute of Cancer Research, London, has been awarded a CBE in the Queen's Birthday Honours list for services to medical sciences.
Drone footage of the MR-Linac magnet being lowered into the ground
Progress with MR Linac radiotherapy machine promises a new era of personalised therapy

09/06/16

Following the delivery of a giant magnet for the groundbreaking MR Linac machine, Dr Claire Bithell considers what its completion will mean for personalised cancer therapy.
The Brookes Lawley Building at the ICR's Sutton site.
Queen awards prestigious Regius Professorship to the ICR

06/06/16

The Institute of Cancer Research, London, has been awarded a highly prestigious Regius Professorship by Her Majesty the Queen to mark her 90th Birthday.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.